Cargando…
Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy
BACKGROUND: The mortality rate of ovarian cancer is the highest among all gynecological malignancies in Japan. Ovarian tumors are classified as benign, borderline malignant, or malignant. Anticipating the histological subtype with imaging only is often difficult because of several histological subty...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120074/ https://www.ncbi.nlm.nih.gov/pubmed/30176911 http://dx.doi.org/10.1186/s13048-018-0449-1 |
_version_ | 1783352199092371456 |
---|---|
author | Okumura, Toshiyuki Muronosono, Etuo Tsubuku, Masahiko Terao, Yasuhisa Takeda, Satoru Maruyama, Masanori |
author_facet | Okumura, Toshiyuki Muronosono, Etuo Tsubuku, Masahiko Terao, Yasuhisa Takeda, Satoru Maruyama, Masanori |
author_sort | Okumura, Toshiyuki |
collection | PubMed |
description | BACKGROUND: The mortality rate of ovarian cancer is the highest among all gynecological malignancies in Japan. Ovarian tumors are classified as benign, borderline malignant, or malignant. Anticipating the histological subtype with imaging only is often difficult because of several histological subtypes of epithelial ovarian tumors (such as serous, mucinous, endometrioid, clear cell, and Brenner tumors). In addition, the majority of mucinous tumors in the ovary are metastatic. Furthermore, mucinous tumors belong to one of the two different subclasses (i.e., intestinal and seromucinous types). Ovarian seromucinous cystic tumors of borderline malignancy are infrequent and only rarely coexist with other malignant tumors. CASE PRESENTATION: We have reported a 53-year-old Japanese woman with anaplastic carcinoma in an ovarian seromucinous cystic tumor of borderline malignancy. Her MRI and CT analysis revealed an ovarian tumor with a mural nodule, ascites, and peritoneal dissemination. Enhanced MRI revealed that the mural nodule was enhanced. Enhanced CT analysis revealed that the lymph nodes were not swollen. Intriguingly, the mural nodule crossed the cyst wall into the cavity and onto the surface. Her laboratory data revealed high serum CA 125 level. Cumulatively, these results suggested ovarian malignancy. The patient underwent hysterectomy with bilateral salpingo-oophorectomy, omentectomy, and resection of the disseminated lesions. Lymph node biopsy was omitted because of the suggestion of enhanced CT image findings and palpation during surgery. Her postoperative specimen examination determined FIGO at least stage IIIB, and accordingly, adjuvant chemotherapy was prescribed. After 3 years of the operation, the patient is presently alive without clinical tumor recurrences. CONCLUSION: Imaging studies with pathognomonic findings contributed to ovarian cancer diagnosis in this case. To the best of our knowledge, this is the first study in English literature to report detailed classification of mucinous borderline malignancy, seromucinous cystic, and anaplastic carcinoma in an ovarian seromucinous cystic tumor of borderline malignancy. |
format | Online Article Text |
id | pubmed-6120074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61200742018-09-05 Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy Okumura, Toshiyuki Muronosono, Etuo Tsubuku, Masahiko Terao, Yasuhisa Takeda, Satoru Maruyama, Masanori J Ovarian Res Case Report BACKGROUND: The mortality rate of ovarian cancer is the highest among all gynecological malignancies in Japan. Ovarian tumors are classified as benign, borderline malignant, or malignant. Anticipating the histological subtype with imaging only is often difficult because of several histological subtypes of epithelial ovarian tumors (such as serous, mucinous, endometrioid, clear cell, and Brenner tumors). In addition, the majority of mucinous tumors in the ovary are metastatic. Furthermore, mucinous tumors belong to one of the two different subclasses (i.e., intestinal and seromucinous types). Ovarian seromucinous cystic tumors of borderline malignancy are infrequent and only rarely coexist with other malignant tumors. CASE PRESENTATION: We have reported a 53-year-old Japanese woman with anaplastic carcinoma in an ovarian seromucinous cystic tumor of borderline malignancy. Her MRI and CT analysis revealed an ovarian tumor with a mural nodule, ascites, and peritoneal dissemination. Enhanced MRI revealed that the mural nodule was enhanced. Enhanced CT analysis revealed that the lymph nodes were not swollen. Intriguingly, the mural nodule crossed the cyst wall into the cavity and onto the surface. Her laboratory data revealed high serum CA 125 level. Cumulatively, these results suggested ovarian malignancy. The patient underwent hysterectomy with bilateral salpingo-oophorectomy, omentectomy, and resection of the disseminated lesions. Lymph node biopsy was omitted because of the suggestion of enhanced CT image findings and palpation during surgery. Her postoperative specimen examination determined FIGO at least stage IIIB, and accordingly, adjuvant chemotherapy was prescribed. After 3 years of the operation, the patient is presently alive without clinical tumor recurrences. CONCLUSION: Imaging studies with pathognomonic findings contributed to ovarian cancer diagnosis in this case. To the best of our knowledge, this is the first study in English literature to report detailed classification of mucinous borderline malignancy, seromucinous cystic, and anaplastic carcinoma in an ovarian seromucinous cystic tumor of borderline malignancy. BioMed Central 2018-09-03 /pmc/articles/PMC6120074/ /pubmed/30176911 http://dx.doi.org/10.1186/s13048-018-0449-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Okumura, Toshiyuki Muronosono, Etuo Tsubuku, Masahiko Terao, Yasuhisa Takeda, Satoru Maruyama, Masanori Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy |
title | Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy |
title_full | Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy |
title_fullStr | Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy |
title_full_unstemmed | Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy |
title_short | Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy |
title_sort | anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120074/ https://www.ncbi.nlm.nih.gov/pubmed/30176911 http://dx.doi.org/10.1186/s13048-018-0449-1 |
work_keys_str_mv | AT okumuratoshiyuki anaplasticcarcinomainovarianseromucinouscystictumorofborderlinemalignancy AT muronosonoetuo anaplasticcarcinomainovarianseromucinouscystictumorofborderlinemalignancy AT tsubukumasahiko anaplasticcarcinomainovarianseromucinouscystictumorofborderlinemalignancy AT teraoyasuhisa anaplasticcarcinomainovarianseromucinouscystictumorofborderlinemalignancy AT takedasatoru anaplasticcarcinomainovarianseromucinouscystictumorofborderlinemalignancy AT maruyamamasanori anaplasticcarcinomainovarianseromucinouscystictumorofborderlinemalignancy |